Proto-oncogene PML controls genes devoted to MHC class I antigen presentation

Nature

Volumn 396, Issue 6709, 1998, Pages 373-376

  Zheng, Pan ^a,c   Guo, Yong ^a   Niu, Qingtian ^a   Levy, David E ^a   Dyck, Jacqueline A ^b   Lu, Shengli ^a   Sheiman, Lori A ^a   Liu, Yang ^a,c  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; CELL LINE; GENE EXPRESSION; GENE REPRESSION; IMMUNE RESPONSE; MOLECULAR CLONING; MOUSE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTO ONCOGENE; TRANSACTIVATION;

3T3 CELLS; AMINO ACID SEQUENCE; ANIMALS; ANTIGEN PRESENTATION; CLONING, MOLECULAR; DNA, COMPLEMENTARY; GENES, REGULATOR; HISTOCOMPATIBILITY ANTIGENS CLASS I; MICE; MOLECULAR SEQUENCE DATA; MUTATION; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PROTEIN ISOFORMS; PROTO-ONCOGENES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

ANIMALIA;

EID: 0032569794     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/24628     Document Type: Article

References (30)

1. White, L. C. et al. Regulation of LMP2 and TAP1 genes by IRF-1 explains the paucity of CD8 T cells in IRF-1(-/-) mice. Immunity 5, 365-376 (1996).
2. Matinez, C. K. & Monaco, J. J. Homology of proteasome subunits to a major histocompatibility complex-linked LMP gene. Nature 353, 554-667 (1991).
3. Trowsdale, J. et al. Sequences encoded in the class II region of the MHC related to the 'ABC' superfamily of transporters. Nature 348, 741-744 (1990).
4. Townsend, A. R. M. et al. The epitope of influenza nucleoprotein recognized by cylotoxic lymphocytes can be defined with short synthetic peptides. Cell 44, 959-968 (1986).
5. Spies, T. et al. A gene in the human major histocompatibiity complex class II region controlling the class I antigen-presentation pathway. Nature 348, 744-747 (1990).
6. Rotem-Yehudar, R., Winograd, S., Sela, S., Coligan, J. E. & Ehrlich, R. Downregulation of peptide transporter genes in cell lines transformed with highly oncogenic adenovirus 12. J. Exp. Med. 180, 477-488 (1994).
7. Rotem-Yehudar, R., Groettrup, M., Soza, A., Kloetzel, P. M. & Ehrlich, R. LMP-associated proteolytic activities and TAP-dependent peptide transport for class I MHC molecules are suppressed in cell lines transformed by the highly oncogenic adenovirus 12. J. Exp. Med. 183, 499-514 (1996).
8. Restifo, N. P. et al. Identification of human cancers deficient in antigen-processing. J. Exp. Med. 177, 265-272 (1993).
9. Korkolopoulou, P., Kaklamanis, L., Pezzella, F., Harris, A. L. & Gatter, K. C. Loss of antigen-presenting molecule (MHC class I and TAP-1) in lung cancer. Br. J. Cancer 73, 148-153 (1996).
10. Vegh, Z., Wang, P., Vanky, F. & Klein, E. Selective down-regulated expression of major histocompatibility complex class I alleles in human solid tumors. Can. Res. 53, 2416-2420 (1993).
11. Ramarathinam, L., Castle, M., Wu, Y. & Liu, Y. T cell costimulation by B7/BB1 induces CD8 T cell-dependent tumor rejection: an important role of B7/BB1 in the induction, recruitment, and effector function of antitumor T cells. J. Exp. Med. 179, 1205-1214 (1994).
12. Ramarathinam, L. et al. Multiple lineages of tumors express a common tumor antigen, P1A, but they are not cross-protected. J. Immunol. 155, 5323-5329 (1995).
13. Steimle, V., Otten, L. A., Zufferey, M. & Mach, B. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bar lymphocyte syndrome). Cell 75, 135-146 (1993).
14. Goddard, A. D. et al. Cloning of the murine homolog of the leukemia-associated PML gene. Mamm. Gen. 7, 732-737 (1995).
15. Perez, A. et al. PML/RAR homodimers: distinct DNA binding properties and heterodimeric interaction with RXR. EMBO J. 12, 3171-3182 (1993).
16. Fagioli, M. et al. Alternative splicing of PML transcripts predicts coexpression of several carboxy-terminally different protein isoforms. Oncogene 7, 1083-1091 (1992).
17. de Thé, H. C. et al. The PML-RARα fusion mRNA generated by the t(15:17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell 66, 675-684 (1991).
18. Goddard, A. D., Borrow, J., Freemont, P. S. & Solomon, E. Characterization of a zinc finger gene disrupted by the t(15;17) in acute promyelocytic leukemia. Science 254, 1371-1374 (1991).
19. Grignani, F. et al. The acute promyelocytic leukemia-specific PML-RARα fusion protein inhibits differentiation and promotes survival of myeloid precursor cells. Cell 74, 423-431 (1993).
20. Kakizuka, A. et al. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RARα with a novel putative transcriptional factor, PML. Cell 66, 663-674 (1991).
21. Yoshida, H. et al. Accelerated degradation of PML-retinoic acid receptor alpha (PML-RARα) oncoprotein by all-trans-retinoic acid in acute promyelocytic leukemia: possible role of the proteasome pathway. Cancer Res. 56, 2945-2948 (1996).
22. Lavau, C. et al. The acute promyelocytic leukemia-associated PML gene is induced by interferon. Oncogene 11, 871-876 (1995).
23. b. EMBO J. 8, 1139-1144 (1989).
24. Gambacorta, M. et al. Heterogeneous nuclear expression of the promyelocytic leukemia (PML) protein in normal and neoplastic human tissue. Am. J. Pathol. 149, 2023-2035 (1996).
25. Koken, M. H. M. et al. The PML growth-suppressor has an altered expression in human oncogenesis. Oncogene 10, 1315-1324 (1995).
26. Carvalho, T. et al. Targeting of adenovirus E1A and E4-ORF3 proteins to nuclear matrix-associated PML bodies. J. Cell. Biol. 131, 45-56 (1995).
27. Durbin, J. E., Hackenmiller, R., Simon, M. C. & Levy, D. E. Targeted disruption of the mouse stall gene results in compromised innate immunity to viral disease. Cell 84, 443-450 (1996).
28. Lanotte, M. et al. NB4, a maturation-inducible cell line with t(15:17) marker isolated from a human promyelocytic leukemia (M3). Blood 77, 1080-1086 (1991).
29. Guo, Y., Wu, Y., Shinde, S. & Liu, Y. Identification of CD44H as a costimulatory molecule rapidly induced by CD40 ligand. J. Exp. Med. 184, 955-961 (1996).
30. Oi, V. T., Morrison, S. L., Herzenberg, L. A. & Berg, P. Immunoglobulin gene expression in lymphoid cells. Proc. Natl Acad. Sci. USA 80, 825-829 (1983).